Skip to main content
Livermore
Livermore
ZHEN

Exchange Traded Concepts, LLC

SEC CIK
0001457320
Latest filing
Aug 11, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Exchange Traded Concepts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
16,688
Value
$1.36M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ARWR by Exchange Traded Concepts, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,688$1.36M<0.1%−2,091−11.1%ReducedHolders
Q1 202618,779$1.18M<0.1%+1,481+8.6%AddedHolders
Q4 202517,298$1.15M<0.1%−13,642−44.1%ReducedHolders
Q3 202530,940$1.07M<0.1%−15,265−33.0%ReducedHolders
Q2 202546,205$730.0K<0.1%−3,042−6.2%ReducedHolders
Q1 202549,247$627.4K<0.1%+11,879+31.8%AddedHolders
Q4 202437,368$702.5K<0.1%−2,924−7.3%ReducedHolders
Q3 202440,292$780.5K<0.1%−8,684−17.7%ReducedHolders
Q2 202448,976$1.27M<0.1%+19,907+68.5%AddedHolders
Q1 202429,069$831.4K<0.1%−14,683−33.6%ReducedHolders
Q4 202343,752$1.34M<0.1%+43,752NewHolders
Q2 20230$00.0%−51,272−100.0%Sold outHolders
Q1 202351,272$1.30M<0.1%+372+0.7%AddedHolders
Q4 202250,900$2.06M0.1%+8,724+20.7%AddedHolders
Q3 202242,176$1.39M<0.1%−7,822−15.6%ReducedHolders
Q2 202249,998$1.76M0.1%−1,846−3.6%ReducedHolders
Q1 202251,844$2.38M<0.1%+30,654+144.7%AddedHolders
Q4 202121,190$1.41M<0.1%−5,385−20.3%ReducedHolders
Q3 202126,575$1.66M<0.1%+5,372+25.3%AddedHolders
Q2 202121,203$1.76M0.1%−1,865−8.1%ReducedHolders
Q1 202123,068$1.53M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.